Reports for METHYLPHENIDATE HYDROCHLORIDE
Ingredient
METHYLPHENIDATE HYDROCHLORIDE
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FOQUEST | 55MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-11-17 | 2022-12-21 | 175191 |
| APO-METHYLPHENIDATE ER | 27MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-11-04 | 2022-12-23 | 173831 |
| APO-METHYLPHENIDATE ER | 36MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-11-27 | 2023-01-06 | 175895 |
| BIPHENTIN | 10MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-12-02 | 2023-01-09 | 176975 |
| FOQUEST | 85MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2022-12-02 | 2023-01-09 | 176978 |
| BIPHENTIN | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-12-15 | 2023-01-10 | 178626 |
| FOQUEST | 70MG | CAPSULE (CONTROLLED RELEASE) | Resolved | 2023-01-05 | 2023-01-10 | 179946 |
| BIPHENTIN | 30MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-01-13 | 2023-01-31 | 180941 |
| APO-METHYLPHENIDATE ER | 54MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-11-20 | 2023-02-09 | 175312 |
| FOQUEST | 35MG | CAPSULE (CONTROLLED RELEASE) | Avoided shortage | 2023-02-03 | 2023-02-16 | 183530 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| SANDOZ METHYLPHENIDATE SR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2022-05-24 | 2022-05-24 | 161221 |